Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-Like cell lesions

被引:82
作者
Vanoli, Alessandro [1 ,2 ]
La Rosa, Stefano [3 ,4 ]
Luinetti, Ombretta [1 ,2 ]
Klersy, Catherine [5 ]
Manca, Rachele [1 ,2 ]
Alvisi, Costanza [6 ]
Rossi, Sandro [7 ]
Trespi, Erminio [7 ]
Zangrandi, Adriano [8 ]
Sessa, Fausto [3 ,4 ]
Capella, Carlo [3 ,4 ]
Solcia, Enrico [1 ,2 ]
机构
[1] Univ Pavia, Dept Pathol, I-27100 Pavia, Italy
[2] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, I-27100 Pavia, Italy
[3] Osped Circolo Varese, Dept Pathol, I-21100 Varese, Italy
[4] Univ Insubria, Dept Surg & Morphol Sci, I-21100 Varese, Italy
[5] Fdn IRCCS Policlin San Matteo, Biometry & Stat Unit, I-27100 Pavia, Italy
[6] Fdn IRCCS Policlin San Matteo, Digest Endoscopy Unit, I-27100 Pavia, Italy
[7] Fdn IRCCS Policlin San Matteo, Dept Internal Med, I-27100 Pavia, Italy
[8] Piacenza Gen Hosp, Anat Pathol Unit, I-29100 Piacenza, Italy
关键词
ECL cell; Dysplasia; Hyperplasia; Neuroendocrine tumor; Preneoplastic lesions; Stomach; MULTIPLE ENDOCRINE NEOPLASIA; ZOLLINGER-ELLISON-SYNDROME; HELICOBACTER-PYLORI; PROGNOSTIC EVALUATION; PERNICIOUS-ANEMIA; CARCINOID-TUMORS; ASSOCIATION; MICRONESTS; STOMACH; MARKER;
D O I
10.1016/j.humpath.2013.02.005
中图分类号
R36 [病理学];
学科分类号
100103 [病原生物学];
摘要
The role of putative preneoplastic enterochromaffin-like cell lesions, either hyperplastic or dysplastic, in the genesis of type 1 enterochromaffin-like cell neuroendocrine tumors associated with type A chronic atrophic gastritis, their actual neoplastic risk, and their precise histogenetic mechanism deserve further clarification by specific histopathologic studies coupled with patient follow-up. A total of 100 patients with severe type A chronic atrophic gastritis, enterochromaffin-like cell hyperplasia, and antral G-cell hyperplasia were endoscopically and histologically followed up for a median of 90.1 months (total of 9118 person-months). Preneoplastic enterochromaffin-like cell lesions and newly developed neuroendocrine tumors were investigated histologically and histochemically, in parallel with enterochromaffin-like cell lesions found in nontumor mucosa of another 32 well-characterized and previously reported type 1 neuroendocrine tumors. Both neuroendocrine and nonneuroendocrine mucosa changes were analyzed and statistically evaluated. During follow-up, 7 of 100 patients developed neuroendocrine tumors: 5 were in a group of 20 cases with previous enterochromaffin-like cell dysplasia and 2 were among 80 cases showing only enterochromaffin-like cell hyperplasia throughout the study (hazard ratio, 20.7; P < .001). The severity of enterochromaffin-like cell hyperplasia at first biopsy, with special reference to linear hyperplasia with 6 chains or more per linear millimeter, also increased the risk of neuroendocrine tumor development during follow-up (hazard ratio, 13.0; P < .001). Enterochromaffin-like cell microinvasive dysplastic lesions arising at the epithelial renewal zone level, in connection with immature proliferating mucous-neck cells, were found to be linked to early intramucosal neuroendocrine tumor histogenesis. Both enterochromaffin-like cell dysplasia and severe hyperplasia indicate increased risk of neuroendocrine tumor development in type A chronic atrophic gastritis with hypergastrinemia/G-cell hyperplasia. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1827 / 1837
页数:11
相关论文
共 38 条
[1]
Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid [J].
Annibale, B ;
Azzoni, C ;
Corleto, VD ;
di Giulio, E ;
Caruana, P ;
D'ambra, G ;
Bordi, C ;
Delle Fave, G .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (12) :1449-1456
[2]
A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: Identification of risk factors [J].
Berna, Marc J. ;
Annibale, Bruno ;
Marignani, Massimo ;
Luong, Tu Vinh ;
Corleto, Vito ;
Pace, Andrea ;
Ito, Tetsuhide ;
Liewehr, David ;
Venzon, David J. ;
Delle Fave, Gianfranco ;
Bordi, Cesare ;
Jensen, Robert T. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05) :1582-1591
[3]
BORDI C, 1991, CANCER-AM CANCER SOC, V67, P663, DOI 10.1002/1097-0142(19910201)67:3<663::AID-CNCR2820670323>3.0.CO
[4]
2-L
[5]
GASTRIC CARCINOIDS OF ARGYROPHIL ECL CELLS [J].
CAPELLA, C ;
POLAK, JM ;
TIMSON, CM ;
FRIGERIO, B ;
SOLCIA, E .
ULTRASTRUCTURAL PATHOLOGY, 1980, 1 (03) :411-418
[6]
THE SYNDROME OF GASTRIC ARGYROPHIL CARCINOID-TUMORS AND NONANTRAL GASTRIC ATROPHY [J].
CARNEY, JA ;
GO, VLW ;
FAIRBANKS, VF ;
MOORE, SB ;
ALPORT, EC ;
NORA, FE .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (06) :761-766
[7]
CORREA P, 1992, CANCER RES, V52, P6735
[8]
Gastric autoimmunity:: the role of Helicobacter pylori and molecular mimicry [J].
D'Elios, MM ;
Appelmelk, BJ ;
Amedei, A ;
Bergman, MP ;
Del Prete, G .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (07) :316-323
[9]
FIOCCA R, 1988, CANCER-AM CANCER SOC, V61, P956, DOI 10.1002/1097-0142(19880301)61:5<956::AID-CNCR2820610517>3.0.CO
[10]
2-C